Military Healthcare Provider Defense Attorney
A summary suspension, adverse privileging action, or DHA peer review hearing can end a military medical career — and follow a provider into civilian practice through NPDB reporting and state licensing notifications. Attorney Patrick Korody has defended military physicians, dentists, nurses, CRNAs, pharmacists, behavioral health providers, and other privileged healthcare providers at MTFs worldwide since 2009 — representing uniformed, civilian, and contractor personnel across every phase of the DHA process.
The biggest mistake providers make after a summary suspension is believing they can explain their way to immediate reinstatement through informal conversation with the MTF. That "talking" is almost always more harmful than helpful — and frequently creates admissions that are used against the provider at the peer review hearing. Contact Korody Law first. Free consultation for summarily suspended providers.
On This Page
- Experience Defending Military Healthcare Providers Since 2009
- Providers We Represent and Allegations We Defend
- The DHA-PM 6025.13 Adverse Privileging Process
- The DHA Peer Review Hearing — A Formal Evidentiary Proceeding
- Possible Hearing Outcomes and What Each Means
- NPDB Reporting — The Consequence That Follows You Out of the Military
- Frequently Asked Questions
- Related Practice Areas
Experience Defending Military Healthcare Providers Since 2009
Attorney Patrick Korody has represented military healthcare providers in clinical privileging and adverse action matters since 2009 — spanning both the service-specific legacy regulatory systems (MEDCOM, BUMED, AFMOA/AFMS) that preceded DHA consolidation and the current centralized DHA framework governed by DHA-PM 6025.13, Volume 3. Having practiced through both eras gives him a perspective that attorneys who entered this field after DHA consolidation cannot match: the institutional culture that still influences how investigations are conducted at individual MTFs — even under the DHA umbrella — is rooted in service-specific traditions that continue to shape how quality assurance officers, credentials committees, and medical staffs approach peer review.
These cases are rarely about perfection. They are about whether the care provided met an appropriate and realistic standard under the circumstances. QAI investigating officers frequently want to sound like the authority on the issue and apply hindsight analysis, impose a "perfect" standard, or assume there is only one acceptable way to practice — a recurring problem with military-trained medical professionals. Effective defense requires disciplined record analysis, careful articulation of the applicable standard of care, and strategic navigation of administrative decision-making dynamics that civilian healthcare lawyers are not equipped to provide.
"These cases are about whether the care provided met an appropriate and realistic standard under the circumstances — not whether it was perfect. The defense exposes flawed standards and hindsight reasoning in the QAI, and demonstrates that the provider is safe, competent, and that there should be no concerns about their ability to practice at the MTF."
— Attorney Patrick Korody
Providers We Represent and Allegations We Defend
Korody Law represents the full range of privileged healthcare providers at military treatment facilities — uniformed officers, civilian government employees, and contractors — across every service component and at MTFs worldwide, from Landstuhl Regional Medical Center in Germany to hospitals and clinics in Okinawa, Hawaii, and across the continental United States.
Provider Types We Represent
- Physicians and surgical subspecialists — including surgeons, orthopedic surgeons, OB/GYN, neurosurgeons, ophthalmologists, and other operative specialists
- Anesthesiologists and CRNAs — anesthesia cases present highly specialized standard-of-care issues requiring both clinical expertise and procedural advocacy
- Emergency medicine physicians — high-acuity, time-pressured clinical decisions that are particularly vulnerable to unfair hindsight analysis
- Primary care and family medicine providers — including both physicians and advanced practice nurses in primary care roles
- Behavioral health professionals — psychologists, psychiatrists, licensed clinical social workers, and licensed professional counselors
- Dentists and dental subspecialists — oral surgeons, periodontists, and general dentists across all service branches
- Pharmacists — prescribing disputes, dispensing concerns, and medication management allegations
- Registered nurses and advanced practice nurses — including nurse practitioners and clinical nurse specialists with independent clinical privileges
- Physical therapists and allied health professionals — privileged rehabilitation and allied health providers at major MTFs
Common Allegations and Adverse Action Bases
- Clinical incompetence — allegations that the provider's care deviated from the applicable standard; the most common basis for adverse privileging actions and the one most susceptible to hindsight analysis by QAI officers
- Deviation from standard of care — specific patient care events that the credentials committee or QAI characterizes as below acceptable practice
- Failed FPPE (Focused Professional Practice Evaluation) — monitoring periods that conclude with adverse findings rather than privilege restoration
- Impairment concerns — substance abuse, mental health, or physical condition allegations affecting practice fitness
- Prescribing disputes — controlled substance prescribing patterns, opioid management concerns, or prescription monitoring flags
- Documentation deficiencies — medical record documentation patterns that draw quality management scrutiny
- Professionalism complaints — interpersonal conduct allegations involving patients, staff, or co-workers
- Professional misconduct — serious allegations including sexual misconduct, boundary violations, or theft of controlled substances
- Pattern-based peer review — cumulative quality management flags that trigger formal review without a single sentinel event
The DHA-PM 6025.13 Adverse Privileging Process
Clinical adverse actions and adverse privileging actions for privileged providers at military treatment facilities are governed by DHA Policy Manual 6025.13, Volume 3, effective October 1, 2019. Understanding the process — and where the defense has the greatest leverage at each stage — is essential to protecting a provider's career and reputation.
Stage 1: Summary Suspension
The summary suspension is typically the first formal indication that an adverse privileging action is underway. The provider receives written notice removing them from clinical practice — effective immediately — based on the privileging authority's determination that patient safety or institutional integrity requires emergency action. After 30 days, the summary suspension is reported to the NPDB. Providers should never attempt to informally resolve a summary suspension through conversation with the MTF without counsel. Contact Korody Law immediately upon receiving a summary suspension notice.
Stage 2: Quality Assurance Investigation (QAI)
After the summary suspension, a QAI is conducted — typically by a designated officer who reviews clinical records, consults with clinical staff, and prepares a written report with findings. The QAI report is the foundational document in the adverse action proceeding. Before the QAI is forwarded to the privileging authority, the provider is entitled to receive it and submit a response. This QAI response opportunity is among the most important rights in the entire process — and one of the most consequential moments for defense intervention.
Stage 3: Proposed Adverse Action & Peer Review Hearing
If the QAI concludes that adverse action is warranted, the privileging authority issues a proposed adverse action notice. The provider then has the right to appear before a Peer Review Panel Hearing — a formal, transcribed evidentiary proceeding that is the primary opportunity to present the defense case, challenge the QAI's findings, present expert testimony, and argue for reinstatement or a less severe outcome. The panel's written recommendation shapes everything that follows.
Stage 4: Privileging Authority Decision and DHA Appeal
After the Peer Review Panel issues its recommendation, the Privileging Authority (typically the MTF commander) issues a final decision. If that decision is adverse, the provider has the right to appeal to the Director of DHA (or the applicable service Surgeon General). Appeals are record-based — limited to the hearing record — which is why building a comprehensive, well-documented hearing record is critical regardless of the initial outcome.
Stage 5: NPDB Reporting and Post-Decision Strategy
A final adverse privileging action — restriction, reduction, or revocation of privileges — is reported to the National Practitioner Data Bank (NPDB) and may be reported to state licensing authorities. NPDB reports follow a provider permanently into civilian practice, affecting hospital credentialing, employment, and malpractice insurance everywhere they work for the rest of their career. Post-decision strategy — including scope-of-practice restructuring, reinstatement monitoring, and NPDB response rights — is part of every case we handle.
Important right often overlooked: Any provider who ends their affiliation — whether they quit, are terminated, or are separated from service — while under a summary suspension or QAI must immediately request in writing that due process procedures continue. The DHA can still adjudicate a final adverse privileging action — and report it to the NPDB — even after a provider has left the MTF. Failure to request continuation of due process does not stop the proceeding; it just eliminates the provider's ability to participate in it.
The DHA Peer Review Hearing — A Formal Evidentiary Proceeding
A DHA Peer Review Hearing is not a routine meeting. It is a formal administrative adjudication conducted under DHA-PM 6025.13, Volume 3 — transcribed verbatim for the official record and governed by defined procedural rules. Witnesses testify under oath. Exhibits are formally admitted. Objections are ruled upon. The panel deliberates and issues written findings. The hearing applies a preponderance of the evidence standard — more likely than not — which makes structured, disciplined advocacy critical. Once the record is created, it becomes the foundation for everything that follows.
Panel Selection — Voir Dire
Before evidence is presented, panel members are sworn and questioned to determine whether they can serve fairly and impartially. This stage functions like voir dire in court. A provider has the right to challenge panel members for cause if bias, prior involvement, or a predisposed attitude exists. An experienced attorney knows what to probe, what answers signal disqualifying bias, and when to challenge. Panel composition can significantly influence how clinical judgment disputes and standard-of-care questions are evaluated — a panel heavily weighted toward a particular specialty may view a generalist's clinical decisions very differently than one drawn from a broader clinical background.
Opening Statement — Setting the Battlefield
The MTF will present its case in a structured manner, relying heavily on the QAI findings. If that narrative is not immediately reframed by defense counsel, it becomes the baseline from which the panel views the entire case. A strong opening establishes the correct and realistic standard of care, draws the critical distinction between clinical judgment and incompetence, explains why hindsight cannot substitute for contemporaneous decision-making, and challenges the "there is only one right way to practice" framing that QAI officers frequently impose. Without disciplined advocacy at the outset, panels can unconsciously adopt the MTF's framing before defense evidence is even heard.
Cross-Examination and Witness Control
The MTF presents its witnesses first — typically the QAI officer and clinical reviewers. The provider has the right to cross-examine each witness. Effective cross-examination exposes inconsistencies in the QAI, highlights incomplete record review, clarifies that multiple reasonable clinical approaches exist for the patient presentation at issue, demonstrates bias or methodological flaws in the review process, and dismantles "perfect standard" reasoning. Panel members may also question witnesses directly — experienced counsel ensures those exchanges stay clinically grounded and aligned with the applicable standard of care.
Documentary Evidence and Objections
The MTF typically introduces the summary suspension memorandum, QAI report, credentials committee recommendations, clinical activity files, and the provider's credentialing records. Because the hearing is administrative — not bound by strict courtroom evidence rules — panels may consider material that would not be admissible in court. Strategic objection and record control are therefore essential. Counsel may object to irrelevant or prejudicial material, expansion beyond the scope of the notice, misstatements of the applicable standard of care, and procedural irregularities affecting due process. Protecting record integrity at the hearing stage is critical because appeals are limited and highly deferential to the existing record.
Defense Case — Expert Evidence and Patient Records
The defense presents its affirmative case after the MTF: detailed clinical record documentation, applicable clinical practice guidelines and evidence-based medicine supporting the care rendered, patient records in the full clinical context that the QAI typically ignored or minimized, character and competency testimony from colleagues and supervisors, and — where appropriate — independent expert analysis from a specialist in the relevant field who can directly address the standard-of-care question. Expert testimony is often the most powerful defense tool in clinical incompetence cases, providing the panel with an authoritative clinical voice that directly challenges the QAI officer's conclusions.
Closing Argument and Record Preservation
Closing argument synthesizes the defense evidence, ties together the theme established in opening, and delivers the final argument for reinstatement or a less severe outcome. It also identifies, for the record, any procedural errors or legal issues that may be grounds for appeal if the panel's recommendation is adverse. Systematic record preservation — ensuring every argument, every objection, and every piece of favorable evidence is clearly documented in the hearing transcript — builds the foundation for the DHA appeal if one becomes necessary.
Possible Hearing Outcomes and What Each Means
After deliberation — typically required within 30 days of hearing completion — the Peer Review Panel issues written findings and recommends one of the following outcomes to the Privileging Authority. Understanding what each outcome means in practice shapes the defense strategy throughout the proceeding.
| Outcome | Status | What It Means | NPDB Reportable? |
|---|---|---|---|
| Reinstatement of Privileges | Favorable | Full restoration of previously granted privileges. No adverse action. Provider returns to unrestricted clinical practice. | No (summary suspension revision-to-report reflecting reinstatement) |
| Reinstatement with Monitoring (FPPE / M&E) | Monitored | Return to practice with structured monitoring and defined performance metrics. Not considered an adverse action under DHA-PM 6025.13, but must be successfully completed to restore unrestricted status. | No (not an adverse privileging action) |
| Restriction of Privileges | Adverse | Temporary or permanent limitation on specific procedures, requiring supervision or concurrence. A written supervision plan is required. Provider may perform restricted activities only under specified oversight. | Yes — if accepted by Privileging Authority |
| Reduction of Privileges | Adverse | Permanent removal of a portion of privileges. The provider may no longer perform certain procedures or services — even under supervision. A permanent change to the scope of practice. | Yes — if accepted by Privileging Authority |
| Revocation of Privileges | Adverse | Permanent removal of all clinical privileges. Provider is removed from patient care duties entirely. The most severe outcome — effectively ending practice at the MTF and significantly impairing credentialing everywhere else. | Yes — if accepted by Privileging Authority |
Restriction, reduction, or revocation — if accepted by the Privileging Authority — triggers mandatory NPDB reporting and notification to state licensing authorities. The difference between reinstatement with monitoring (not reportable) and restriction (reportable) can be the difference between a career that continues normally and one permanently marked in every credentialing database in the country.
NPDB Reporting — The Consequence That Follows You Out of the Military
The National Practitioner Data Bank (NPDB) is a federal database that every hospital, health system, managed care organization, and licensing authority in the country queries when credentialing a healthcare provider. An adverse NPDB report does not stay at the MTF — it follows the provider permanently into every credentialing and employment application they make for the rest of their career. Understanding how NPDB reporting works — and how to challenge it — is an essential part of every military provider defense.
What Gets Reported to the NPDB
- Summary suspensions — reported to the NPDB after 30 days of suspension. A revision-to-report is made when the process concludes, updating the entry to reflect the final decision. However, the initial report remains in the database and is visible to querying entities.
- Final adverse privileging actions — restriction, reduction, or revocation of privileges accepted by the Privileging Authority are reported as adverse clinical privilege actions.
- State licensing board actions — notifications sent by DHA to state licensing authorities can trigger parallel state licensing proceedings that generate their own NPDB-reportable actions.
- Actions taken after departure — DHA can complete an adverse privileging proceeding and report to the NPDB even after the provider has left the MTF, if due process procedures were not properly invoked upon departure.
Protecting Your Record — NPDB Rights and Strategy
- Statement rights: A provider who is the subject of an NPDB report has the right to submit a statement disputing the accuracy of the report or providing context — a statement that appears alongside the adverse report whenever it is queried
- Dispute process: Factual inaccuracies in an NPDB report can be challenged through the NPDB's formal dispute resolution process
- Post-decision strategy: Following an adverse privileging action, we advise on scope-of-practice restructuring, reinstatement monitoring programs, and approaches to credentialing and state licensing applications that present the provider's history in the most favorable context
- Contesting summary suspension reporting: Attorney Korody is actively challenging DHA's practice of reporting summary suspensions to the NPDB in ways that may not comply with the applicable NPDB regulations — an area where the regulation and DHA practice are not fully aligned
30-Day Rule: After 30 days, a summary suspension is reported to the NPDB regardless of the proceeding's status. It is exceedingly rare for a provider to be reinstated before this deadline. The priority at the summary suspension stage is not reinstatement within 30 days — it is building the defense for the QAI response and peer review hearing that follows.
Summarily Suspended or Facing a Peer Review Hearing? Call Now.
Attorney Patrick Korody has defended military healthcare providers at MTFs worldwide since 2009. Free consultation for summarily suspended providers. Contact us today — the earlier in the process, the more we can do.
Frequently Asked Questions
-
A summary suspension is an emergency removal from clinical practice — the first formal indication that a provider is being investigated for clinical incompetence, impairment, or professional misconduct. You will receive written notice that includes certain rights outlined in DHA-PM 6025.13, Volume 3. The most important thing to do immediately is contact experienced legal counsel — not attempt to explain yourself to the MTF. The biggest mistake providers make at the summary suspension stage is believing they can talk their way to reinstatement. That conversation almost always creates admissions that are used against them at the peer review hearing. Contact Korody Law first. We offer a free consultation for summarily suspended providers.
-
Yes — after 30 days, the summary suspension is reported to the NPDB. A revision-to-report is made when the process concludes, updating the entry to show the final decision — reinstatement or adverse clinical action. It is exceedingly rare for a provider to be reinstated before the 30-day deadline elapses. Attorney Korody is actively challenging DHA's summary suspension NPDB reporting practices in cases where the reporting does not comply with applicable NPDB regulations. The priority at the summary suspension stage is building the strongest possible defense for the QAI response and peer review hearing that follow.
-
Rarely a good idea — and with a critical caveat. Contractors may be terminated or placed in unpaid status, making the decision for them. Military members could request separation. Civilians employed at will can resign. However, any provider who ends affiliation while under a summary suspension or QAI must immediately request in writing that due process procedures continue. DHA can complete the adverse privileging proceeding and report to the NPDB even after the provider has left — and if the provider fails to request continuation, they lose the right to participate in the process that determines what goes on their permanent NPDB record. This is a case-by-case decision that should never be made without counsel.
-
The Peer Review Panel applies a preponderance of the evidence standard — meaning the panel need only conclude that the allegation is more likely than not true. This is a significantly lower standard than beyond a reasonable doubt in a criminal proceeding, or even clear and convincing evidence used in some administrative contexts. That lower threshold makes the quality of the advocacy at the hearing critically important — the defense must present affirmative evidence supporting the provider's care, not simply argue that the government has not proved its case beyond doubt.
-
Under DHA-PM 6025.13, Volume 3, the three most important rights are: (1) the right to receive and respond to the QAI before it is forwarded to the privileging authority — this response opportunity is one of the most consequential defense moments in the entire process; (2) the right to appear before a Peer Review Hearing — a formal, transcribed, evidentiary proceeding that is the primary opportunity to present the defense case; and (3) the right to appeal the privileging authority's final decision to DHA. There are also separate rights under NPDB regulations to submit a statement or challenge an NPDB entry.
-
No. Reinstatement with monitoring — whether through FPPE or a Monitoring and Evaluation plan — is not considered an adverse privileging action under DHA-PM 6025.13 and is not reported to the NPDB. This distinction is critically important for providers whose cases are finely balanced between a monitored return to practice and a restriction. A restriction is NPDB-reportable; monitoring is not. The difference between those two outcomes — and the advocacy that produces the better one — can determine whether a provider's credentialing and employment are permanently affected or whether they return to normal practice after a defined evaluation period.
-
Yes. Korody Law represents military healthcare providers at MTFs worldwide — including major overseas facilities such as Landstuhl Regional Medical Center in Germany, U.S. facilities in Japan (including Okinawa), South Korea, Guam, and elsewhere. We coordinate by secure phone and video conference and travel to the location of the peer review hearing where in-person appearance is required and strategically beneficial. Geographic location is not an obstacle to representation.
Related Practice Areas
Military healthcare provider adverse privileging actions frequently intersect with UCMJ disciplinary proceedings, administrative separation, and security clearance actions. Korody Law handles all of them in a coordinated strategy.
Court-Martial Defense
Professional misconduct allegations — particularly sexual misconduct or controlled substance theft — often generate parallel UCMJ proceedings alongside the DHA adverse privileging action.
View Court-Martial Defense →Administrative Separation Boards
Uniformed military healthcare providers facing adverse privileging actions may simultaneously face ADSEP or BOI proceedings. We defend both simultaneously.
View ADSEP Defense →Board of Inquiry (Officers)
Officer physicians, dentists, and nurses facing BOI and show cause proceedings alongside adverse privileging actions require integrated strategy across both forums.
View BOI Defense →Security Clearance Defense
Certain adverse privileging actions — particularly those involving substance abuse or professional misconduct — can trigger parallel security clearance proceedings.
View Clearance Defense →Military Criminal Investigations
NCIS, CID, or OSI may investigate conduct that triggers adverse privileging action. Coordinated criminal and administrative defense from day one is essential.
View Investigation Defense →All Practice Areas
Korody Law's full military and federal administrative defense practice — one firm for every battlefield a military provider faces.
View All Practice Areas →Your Clinical Privileges. Your Career. Your License. Defend All Three.
Attorney Patrick Korody has defended military healthcare providers at MTFs worldwide — from summary suspension through QAI response, peer review hearing, DHA appeal, and NPDB strategy — since 2009. Contact us today for a free and confidential consultation. There is no cost to speak with us.
Korody Law, P.A. · Jacksonville, FL · Military Healthcare Provider Defense · Worldwide MTF Representation
